TY  - JOUR

T1  - Radium-223 dichloride (Ra-223) efficacy and safety in patients with castration-resistant prostate cancer (CRPC) with bone metastases: Phase 3 ALSYMPCA study findings stratified by age group

JO  - ONCOLOGY RESEARCH AND TREATMENT

PY  - 2014/10/01

AU  - Wedel S

AU  - Wiechno P

AU  - Helle SI

AU  - Logue J

AU  - Nilsson S

AU  - Sartor O

AU  - Coleman RE

AU  - Kliment J

AU  - Fang F

AU  - Parker C

ED  - 

VL  - 37

SP  - 86

EP  - 87

Y2  - 2025/10/10

ER  -